Stockreport

Take Advantage Of Poor Market Sentiment And Buy Esperion Therapeutics [Seeking Alpha]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF Summary Introduction In early May, Esperion Therapeutics ( ESPR ) released data from their first Phase III clinical trial, investigating their lead agent, bemped [Read more]